This content is machine translated Sleep apnea and cardiovascular diseases Breathless through the night 936 million people affected worldwide, a cardiovascular risk profile that complements traditional risk factors and new pharmacological treatment options: Current evidence from 2024-2026 paints a clearer picture of a link...…
View Post 6 min This content is machine translated Acute pulmonary embolism: new AHA/ACC guideline Practical recommendations for risk-stratified triage In February 2026, the American Heart Association (AHA) and the American College of Cardiology (ACC) published a new guideline on the assessment and treatment of acute pulmonary embolism in cooperation...…
View Post 13 min This content is machine translated Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology Lp(a): The underestimated risk factor before the turning point One in five people worldwide has a genetically elevated lipoprotein(a) – and knows nothing about it. Unlike LDL cholesterol, this independent, causally significant risk factor cannot be significantly influenced by...…
View Post 14 min This content is machine translated Heart failure and type 2 diabetes Oral semaglutide and cardiac decompensation in type 2 diabetes The secondary analysis of the SOUL trial from JAMA Internal Medicine 2026 proves for the first time: Oral semaglutide significantly reduces heart failure events in patients with pre-existing HFpEF –...…
View Post 12 min This content is machine translated Current evidence, risk classes and new counseling options Hormonal contraception and cardiovascular risk Over 247 million women worldwide use hormonal contraception – the majority with combined oral contraceptives (COCs). This prevalence is accompanied by an ongoing medical responsibility: venous thromboembolism, ischemic strokes and...…
View Post 13 min This content is machine translated MACE risk, heart failure incidence and all-cause mortality Metabolic syndrome as a cardiovascular risk factor Current data from 2025/2026 show: 1.54 billion adults worldwide are affected – and the risk of serious cardiovascular events increases in proportion to the number of components. New evidence on...…
View Post 9 min This content is machine translated Cardiology Minimally invasive – the quiet triumph of modern heart surgery The median sternotomy was the standard approach for cardiac surgery for many decades. With the advent of minimally invasive procedures, the guiding question of cardiac surgery shifted: away from maximum...… CME-Test
View Post 10 min This content is machine translated Patients with leg swelling DVT and other common DDs with peripheral edema Swelling of the lower extremities is common, especially in older adults. Due to the complex interrelationships, the clarification of such findings in general practice is a challenge. The differential diagnostic...…
View Post 5 min This content is machine translated Atrial fibrillation Anticoagulation after catheter ablation – for how long? In selected groups of patients with atrial fibrillation, ablation can lead to an improvement in symptoms and/or prognosis. To avoid complications, anticoagulation before, during and after ablation should be criteria-driven....…
View Post 6 min This content is machine translated Treatment of type 2 diabetes: paradigm shift continues Cardiorenal organ protection is increasingly coming to the fore Nowadays, the improvement of the cardiorenal prognosis in patients with type 2 diabetes is largely independent of the current metabolic situation. The focus of patient-oriented treatment is on quality of...…
View Post 4 min This content is machine translated Semaglutide and tirzepatide in HFpEF and T2D/obesity Prospect of improved cardiovascular prognosis Patients suffering from heart failure with preserved ejection fraction (HFpEF) are very often also affected by cardiometabolic comorbidities such as obesity and type 2 diabetes. Although previous randomized trials suggest...…
